
Helvetica Chimica Acta p. 1181 - 1200 (1998)
Update date:2022-08-03
Topics:
Seebach, Dieter
Poenaru, Sorana
Folkers, Gerd
Rognan, Didier
In the center of the immune system, there are major histocompatibility (MHC) protein/nonapeptide complexes which are recognized by T cells. The nonapeptides consist of three regions, an N-terminal one containing three amino-acid residues with a mandatory arginine in position 2, a C-terminal one with a lysine or arginine in position 9, and a central, variable one of five residues (cf. Fig. 1). We have now synthesized the first conjugates (1-4) of oligopeptides with oligo[(R)-3-hydroxybutanoates] (OHB) as analogs of MHC-binding peptides. Of the approaches chosen (Scheme 1), a fragment coupling of a hydroxy-butanoyl-amido ester (17 and 19) with an [(aminoalkanoyl)oxy]butanoyl chloride (27; Scheme 3), followed by two peptide-coupling steps (Scheme 4), turned out to be most efficient. The conjugates H-Gln-Arg-Leu-(HB)3,4-Lys-OH (1 and 2) and H-Ala-Arg-Leu-(HB)3,4-Lys-OH (3 and 4) were thus obtained in pure form. The conjugates 1 and 2 with N-terminal glutamine have a tendency to undergo cyclization with formation of a pyroglutamate residue (cf. Fig. 2). CD Measurements at different temperatures and so-called epitope-stabilization assays show that the complexes of the conjugates 2 and 4, containing four HB units, with the HLA-B27 class-I-MHC protein are more stable than those of a model nonapeptide (C50 values of 2.25 and 1.60 μM vs. 10 μM), while the conjugates 1 and 3 with three HB units incorporated form less stable complexes (C50 values of 30 and 21 μM). The tetra(hydroxybutanoate)-peptide conjugates 2 and 4 are the first nonapeptide analogs for which the modification of the central part leads to increased affinities for a class-I-MHC protein, as compared to a model nonapeptide.
View MoreContact:+86 021-51698675
Address:1701, Jielong Plaza, No.618 Pingliang Rd, ShangHai,China
Contact:86-510-82853889
Address:Rm.3732, No.18-2,Yonghe Rd.,Wuxi,Jiangsu,214023,China
Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
website:http://www.jlpharms.com
Contact:86-571-86982636
Address:Rm A606, Fuyi Center, jianqiao street
Contact:+86-515-88356562
Address:No.2, West Daqing Road, Yancheng, Jiangsu, China
website:https://en.yan-xi.com/
Contact:+86 17531190177--
Address:Zhang zhe, guangzong county, xingtai city, hebei province
Doi:10.1016/S0040-4039(98)00730-8
(1998)Doi:10.1080/00397919808004834
(1998)Doi:10.1007/BF02320330
(1997)Doi:10.1021/acschemneuro.7b00217
(2017)Doi:10.1021/jm061319i
(2007)Doi:10.1021/ma3016135
(2012)